FTD can be pathologically described based on the accumulation of abnormal protein as tau positive or tau-negative/ubiquitin-positive inclusions (comprising TAR DNA-binding protein 43 and FUS inclusions). This evidence concerns the gene MAPT and frontotemporal dementia.